From 1998-2002, the median age at death for acute myeloid leukemia was 71 years of age. The percentages of people who died from AML based on age were as follows:
- 2.9 percent died under age 20
- 3.7 percent between 20 and 34
- 4.8 percent between 35 and 44
- 8.4 percent between 45 and 54
- 13.9 percent between 55 and 64
- 26.1 percent between 65 and 74
- 29.8 percent between 75 and 84
- 10.3 percent 85+ years of age.
The age-adjusted acute myeloid leukemia death rate was 2.6 per 100,000 men and women per year in the United States.
Cancer patients and their loved ones face many unknowns. While some people find it easier to cope when they know the statistics, other people find statistical information confusing and frightening, and they think that it is too impersonal to be of use to them. The doctor who is most familiar with a patient's situation is in the best position to discuss the prognosis and to explain what the statistics may mean for that person. At the same time, it is important to understand that even the doctor cannot tell exactly what to expect. In fact, a person's prognosis may change if the cancer progresses or if treatment is successful. Seeking information about the AML prognosis is a personal decision, and it is up to each patient to decide how much information he or she wants to know and how to deal with it.